Table 2.

Potential newly emerging biomarkers and their clinical utility in ovarian cancer care.

Emerging Biomarkers	Source	Potential Clinical Role	Reference
Cu isotope	Serum	Early diagnostic tool	[46]
Exosomes	Ascites	Cancer progression	[47]
lncRNA and mRNA	Tumour tissue	Early diagnostic tool and cancer therapy	[48]
Aldehyde Dehydrogenase 1 (ALDH1)	Blood/Cytosol	Early diagnostic and cancer progression	[49]
Folate Receptor Alpha (FOLR1)	Blood/Gene	Progression and cancer therapy	[50]
Glutathione S-Transferase Polymorphisms (GSTP)	Blood/DNA	Anticancer drug response	[51]